Following knockdown or pharmacological inhibition of mutant ALK in NB, we performed transcriptome profiling and found that downstream signaling is mediated through the RAS/MAPK and PI3K/AKT pathways [129]. This evidence concerns the gene AKT1 and neuroblastoma.